Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wegovy under the microscope: Real-World weight loss study begins

NCT ID NCT07055607

ENROLLING_BY_INVITATION Disease control Sponsor: Novo Nordisk A/S Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 4 times

Summary

This two-year study will follow 1,250 people with obesity who are starting Wegovy (semaglutide) as part of their regular medical care. Researchers will track changes in weight, waist size, and quality of life to see how the drug performs outside of clinical trials. The goal is to understand the real-world impact of Wegovy when prescribed by doctors in everyday practice.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
semaglutide (Wegovy)
What this could lead to
If successful, this study could show how well Wegovy works for weight loss in everyday medical practice, not just in controlled trials.
What could go wrong
This is an observational study, not a controlled experiment, so results may be influenced by factors like patient selection or adherence. It does not test a new treatment or prove long-term safety.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY

Contacts and locations

Locations

  • Barnsley Hospital

    Barnsley, S75 2EP, United Kingdom

  • CAP Sants

    Barcelona, 08028, Spain

  • CAP Sarrià

    Barcelona, 08017, Spain

  • Centre médical de l'obésité et du diabète

    Neuchâtel, 2000, Switzerland

  • Centro de Salud Cartagena Casco Antiguo

    Cartagena, 30201, Spain

  • Centro de Salud La Cuesta

    La Cuesta (Santa Cruz de Tenerife), 38320, Spain

  • Clinica Moncucco

    Lugano, 6900, Switzerland

  • Clínica de Endocrinología y Nutrición Dr. Bellido

    Ferrol, 15401, Spain

  • Ginegetafe S.L.

    Getafe (Madrid), 28901, Spain

  • Hospital Quirónsalud Málaga

    Málaga, 29004, Spain

  • Hospital Son Espases

    Palma de Mallorca, 07120, Spain

  • Hospital Univ. Central de Asturias

    Oviedo, 33011, Spain

  • Hospital Univ. Virgen de la Arrixaca

    El Palmar (Murcia), 30120, Spain

  • Hospital Univ. de Gran Canaria Doctor Negrín

    Las Palmas de Gran Canaria, 35010, Spain

  • Hospital Universitario Sanitas Virgen del Mar

    Madrid, 28016, Spain

  • Hospital Vall d'Hebron

    Barcelona, 08035, Spain

  • Hospital Vithas Sevilla

    Castilleja de la Cuesta, 41950, Spain

  • Hospiten Roca_Ginecología

    San Bartolomé de Tirajana (Las Palmas), 35100, Spain

  • Hull Royal Infirmary

    Hull, HU3 2JZ, United Kingdom

  • Hôpitaux Universitaires de Genève HUG

    Geneva, 1211, Switzerland

  • Kantonsspital Olten

    Olten, 4600, Switzerland

  • Luton and Dunstable University Hospital

    Luton, LU4 0DZ, United Kingdom

  • Luzerner Kantonsspital

    Lucerne, 6004, Switzerland

  • Praxis Dr. Schäfer, Bern

    Bern, 3013, Switzerland

  • Praxis Prof. Dr. med. G. Rudofsky

    Olten, 4600, Switzerland

  • Sandwell Health Campus

    West Bromwich, West Midlands, B71 4HJ, United Kingdom

  • St George's Hospital

    Tooting, SW17 0RE, United Kingdom

  • St Thomas' Hospital - Diabetes

    London, SE1 7EH, United Kingdom

  • Stoffwechselzentrum St. Gallen

    Sankt Gallen, 9016, Switzerland

  • Universitätsspital Zürich

    Zurich, 8091, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.